HPS Pharmacies wish to give notice that Phebra has updated the packaging of Potassium Chloride 22.3% Concentrated Injection as follows:
Potassium Chloride 22.3% Concentrated Injection
Potassium Chloride 2.23 g/10 mL
This product is now supplied with a green seal/cap. There has been no change to the formulation of this product.
Concentrated injections of potassium chloride are high risk medications. Always read the label carefully rather than relying on packaging or label recognition when selecting this product.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Phebra on 1800 720 020 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates